How AI can help to tackle COVID-19

Loubna Bouarfa
CEO, Okra Technologies, Cambridge, UK

Michel Bouvier
CEO, Institute for Research in Immunology and Cancer, Université de Montréal, Canada

Giovanni Briganti
Senior fellow, I3h Institute, Université libre de Bruxelles, Belgium

Michel Goldman
Founder of the I3h Institute

Philippe Moingeon
Head of Immuno-inflammation, Servier Pharmaceuticals, Neuilly-sur-Seine, France